Bacterial Lipoprotein and Lipopolysaccharide Act Synergistically to Induce Lethal Shock and Proinflammatory Cytokine Production

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 4868-4878

  Zhang, Hongwei ^a   Peterson, Johnny W ^a   Niesel, David W ^a   Klimpel, Gary R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSAMINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; C3H MOUSE; DRUG POTENTIATION; ESCHERICHIA COLI; FEMALE; GENETICS; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE ACTIVATION; MOUSE; MUTATION; PATHOLOGY; SEPTIC SHOCK;

ANIMALS; DRUG SYNERGISM; ESCHERICHIA COLI; FEMALE; GALACTOSAMINE; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MACROPHAGE ACTIVATION; MICE; MICE, INBRED C3H; MUTATION; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031573217     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Glauser, M. P., G. Zanetti, J. D. Baumgartner, and J. Cohen. 1991. Septic shock: pathogenesis. Lancet 338:732.
2. Bone, R. C. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 115:457.
3. Parrello, J. E. 1993. Pathogenic mechanisms of septic shock. N. Engl. J. Med. 328:1471.
4. Natanson, C., W. D. Hoffman, A. F. Suffredini, P. Q. Erchacker, and R. L. Dabber. 1994. Selected relevant strategies for septic shock based on proposed mechanisms of pathogenesis. Ann. Intern. Med. 120:771.
5. Morrison, D. C., and J. L. Ryan. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med. 38:417.
6. Dinarello, C. A. 1996. Cytokines as mediators in the pathogenesis of septic shock. Curr. Top. Microbiol. Immunol. 216:134.
7. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869.
8. Freudenberg, M. A., and C. Galanos. 1991. Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect. Immun. 59:2110.
9. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662.
10. Stone, R. 1994. Search for sepsis drugs goes on despite past failures. Science 264:365.
11. Barriere, S. L., and B. J. Guglielmo. 1992. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies. Clin. Pharmacol. 11:255.
12. Gorelick, K. J., and H. Chmel. 1991. The role of monoclonal-antibodies in the management of gram-negative sepsis: experience with the E5 antibody. Infect. Dis. Clin. North Am. 5:899.
13. Lehmann, V., M. A. Freudenberg, and C. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165:657.
14. Galanos, C., M. A. Freudenberg, and W. Reutter. 1979. Galactosamine-induced sensitization to the lethal effects of LPS. Proc. Natl. Acad. Sci. USA 76:5939.
15. Freudenberg, M. A., and C. Galanos. 1991. Tumor necrosis factor alpha mediates lethal activity of killed-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect. Immun. 59:2110.
16. Bucklin, S. E., and D. C. Morrison. 1995. Differences in therapeutic efficacy among cell-wall-active antibiotics in a mouse model of gram-negative sepsis. J. Infect. Dis. 172:1519.
17. Evans, T. J., E. Strivens, A. Carpenter, and J. Cohen. 1993. Differences in cytokine response and indication of nitric oxide syntheses in LPS-resistant and LPS-sensitive mice after intravenous Gram-negative infection. J. Immunol. 150: 5033.
18. Carpenter, A., T. J. Evans, W. A. Buurman, M. H. Bremelmans, D. Moyes, and J. Cohen. 1995. Differences in the shedding of soluble TNF receptors between LPS-sensitive and LPS-resistant mice in response to LPS or live bacterial challenge. J. Immunol. 155:2005.
19. Cross, A. S., J. C. Sadoff, W. Kelly, E. Brenton, and P. Gemski. 1989. Pretreatment with TNFα and IL1 protects mice from lethal bacterial infection. J. Exp. Med. 169:2021.
20. 3H lineage. Infect. Immun. 36: 696.
21. 3H mouse strains are equally susceptible to an induced E. coli urinary tract infection. Infect. Immun. 64:1369.
22. 3H/HeJ lymphocytes. J. Exp. Med. 144:821.
23. Goodman, R. L., D. White, and L. Leive. 1981. Identification of outer membrane proteins including known lymphocyte mitogens of the endotoxin protein of E. coli 0111. J. Immunol. 127:1290.
24. Betz, S., and D. C. Morrison. 1977. Chemical and biological properties of a protein-rich fraction of bacterial LPS: the in vitro murine lymphocyte response. J. Immunol. 119:1475.
25. 3HJHeJ spleen cells. J. Exp. Med. 144:840.
26. Goodman, G., and B. Sultzer. 1979. Further studies on the activation of lymphocytes by endotoxin protein. J. Immunol. 122:1329.
27. Bessler, W., and B. Ottenbreitt. 1977. Studies of lipoprotein from the outer membrane of E. coli. Biochem. Biophys. Res. Commun. 76:239.
28. Bessler, W., and U. Henning. 1979. Protein I and protein II from the outer membrane of E. coli are mouse B-lymphocyte mitogens. Z. Immunitaetsforsch. 155: 387.
29. DiRienzo, J. M., Nakamura, and M. Inouye. 1978. The outer membrane proteins of gram-negative bacteria: biosynthesis, assembly, and functions. Annu. Rev. Biochem. 47:481.
30. Braun, V., and K. Hantke. 1974. Biochemistry of bacterial cell envelopes. Annu. Rev. Biochem. 43:89.
31. Braun, V. 1975. Covalent lipoprotein from the outer membrane of E. coli. Biochim. Biophys. Acta 415:335.
32. Melchers, F., V. Braun, and C. Galanos. 1975. The lipoprotein of the outer membrane of E. coli: a B lymphocyte mitogen. J. Exp. Med. 142:473.
33. Biesert, L., W. Scheuer, and W. G. Bessler. 1987. Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytes: isolation and characterization of binding proteins. Eur. J. Biochem. 162:651.
34. Hauschildt, S., P. Hoffmann, H. U. Beuscher, G. Dufhus, P. Heinrich, K. H. Weismuller, G. Jung, and W. G. Bessler. 1990. Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide cytokine production phagocytosis and la expression. Eur. J. Immunol. 20:63.
35. Bessler, W. G., and B. P. Ottenbrit. 1977. Studies on the mitogenic principle of lipoprotein from the outer membrane of E. coli. Biochem. Biophys. Res. Commun. 76:239.
36. Bessler, W. G., K. Resch, E. Hancock, and K. Hantke. 1977. Induction of lymphocyte-proliferation and membrane changes by lipoprotein derivatives of the lipoprotein from the outer membrane of E. coli. Z. Immunitaetsforsch. 153:11.
37. Bessler, W. G., M. Cox, A. Lex, B. Suhs, K. H. Wiesmuller, and C. Jung. 1985. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes. J. Immunol. 135:1900.
38. Hauschildt, S., P. Hoffman, H. U., Beuscher, G. Dufhues, P. Henrick, K. H. Wiesmuller, C. Jung, and W. G. Bessler. 1990. Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and la expression. Eur. J. Immunol. 20:63.
39. Hoffman, P., S. Heinle, U. F. Schade, H. Loppnow, A. J. Ulmer, H. D. Flad, G. Jung, and W. G. Bessler. 1988. Stimulation of human and mouse adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immun. Biol. 177:158.
40. Hirota, Y., H. Suzuki, Y. Nishimura, and S. Yasuda. 1977. On the process of cellular division of E. coli: a mutant of E. coli lacking a murein-lipoprotein. Proc. Natl. Acad. Sci. USA 74:1417.
41. Zhang, H., I. Kaur, D. W. Niesel, G. S. Seetharamaiah, J. W. Peterson, B. S. Prabhakar, and G. R. Klimpel. 1997. Lipoprotein from Yersinia enterocolitica contains epitopes that crossreact with the human thyrotropin receptor. J. Immunol. 158:1976.
42. Guoyang, L., G. S. Seetharamariah, D. W. Niesel, J. W. Peterson, B. S. Prabhakar, and G. R. Klimpel. 1994. Purification and characterization of Yersinia enterocolitica envelope proteins that induce antibodies which react with the human thyrotropin receptor. J. Immunol. 152:2555.
43. Inouye, S., K. Takeishi, N. Lee, M. DeMartini, A. Hiroshima, and M. Inouye. 1976. Lipoprotein from the outer membrane of Escherichia coli: purification, paracrystallization and some properties of its free form. J. Bacteriol. 127:555.
44. Klimpel, G. R. 1980. Soluble factor(s) from LPS-activated macrophages induce cytotoxic T cell differentiation from alloantigen-primed spleen cells. J. Immunol. 125:1243.
45. Klimpel, G. R., K. B. Langley, J. Wypych, J. A. Abrams, A. K. Chopra, and D. W. Niesel. 1996. A role for stem cell factor and c-kit in the intestinal tract response to Salmonella infection. J. Exp. Med. 184:271.
46. Echtenacher, B., W. Falk, D. N. Mannel, and P. H. Krammer. 1990. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 45:3762.
47. Klimpel, G. R., M. Asuncion, J. Haithcoat, and D. W. Niesel. 1995. Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract. Infect. Immun. 63:1134.
48. Binkley, F., W. F. Goebel, and E. Perlman. 1945. Studies in the Flexner group of dysentery bacilli. II. The chemical degradation of the specific antigen of type Z. Shigella paradysenteriae (Flexner). J. Exp. Med. 81:331.
49. Braun, V., and V. Bosch. 1972. Repetitive sequence in the murein-lipoprotein of the cell wall of E. coli. Proc. Natl. Acad. Sci. USA 69:970.
50. Yamagata, H., K. Nakamura, and M. Inouye. 1981. Comparison of the lipoprotein gene among the Enterobacteriaceae. J. Biol. Chem. 256:2194.
51. Hantke, K., and V. Braun. 1973. Covalent binding of lipid protein: diglyceride and amide-linked fatty acid at the N-terminal end of the murein-lipoprotein of the E. coli outer membrane. Eur. J. Biochem. 34:284.
52. Braun, V., H. Rotering, J. P. Ohms, and H. Hagenmaier. 1976. Conformational studies on murein-lipoprotein from the outer membrane of E. coli. Eur. J. Biochem. 70:601.
53. Weismuller, K. H., W. G. Bessler, and G. Jung. 1992. Solid phase peptide synthesis of lipoprotein vaccines eliciting epitope-specific B, T and T-killer cell response. Int. J. Peptide Protein Res. 40:255.
54. Deres, K., H. Schild, K. H. Weismuller, G. Jung, and H. G. Rammensee. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342:561.
55. Vogel, S. N. 1992. The lps gene: insights into the genetic and molecular bases of LPS responsiveness and macrophage differentiation. In Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. B. Beutler, ed. Raven Press, New York, p. 485.
56. Lei, M. G., and D. C. Morrison. 1991. Specific endotoxin (LPS) binding problems on murine splenocytes. I. Detection of LPS-binding sites on splenocytes and splenocyte subpopulations. J. Immunol. 141:996.
57. Gregory, S. H., D. H. Zimmerman, and M. Kern. 1980. The lipid A moiety of LPS is specifically bound to B-cell subpopulations of responder and nonresponder animals. J. Immunol. 125:102.
58. 3H/HeJ defect. Immunobiology 187:257.
59. d) mice respond to LPS by activating NF-κB. J. Leukocyte Biol. 57:174.
60. Pin-Yu, P., N. Qureshi, and S. N. Vogel. 1996. Paclitaxel (taxol)-induced NF-κB translocation in murine macrophages. Infect. Immun. 64:878.
61. d macrophage. J. Immunol. 153:2653.
62. Liu, J., S. Mathias, Z. Yang, and R. N. Kolesnick. 1994. Renaturation and tumor necrosis factor-alpha stimulation of a 97-kDa ceramide-activated protein kinase. J. Biol. Chem. 269:3047.
63. Dobrowsky, R. T., and Y. A. Hannun. 1993. Ceramide-activated protein phosphatase: partial purification and relationship to protein phosphatase 2A. Adv. Lipid Res. 25:91.
64. Joseph, C. K., S. D. Wright, W. G. Bornmann, J. T. Randolph, E. R. Kumar, R. Bittman, J. Liu, and R. N. Kolesnick. 1994. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J. Biol. Chem. 269:17606.
65. d) mice. J. Immunol. 155:2303.
66. Carpenter, A., T. J. Evans, W. A. Buurman, M. H. Bemelmans, D. Moyes, and J. Cohen. 1995. Differences in the shedding of soluble TNF receptors between endotoxin-sensitive and endotoxin-resistant mice in response to LPS or live bacterial challenge. J. Immunol. 155:2005.
67. d phenotype. J. Exp. Med. 164:1791.
68. Freudenberg, M. A., Y. Kumazawa, S. Meding, J. Langhorne, and C. Galanos. 1991. IFNγ production in endotoxin-responder and -nonresponder mice during infection. Infect. Immun. 59:3484.
69. DeOgny, L., B. C. Pramanik, L. L. Arndt, J. D. Jones, J. Rush, C. A. Slaughter, J. D. Radolf, and M. V. Norgard. 1994. Solid-phase synthesis of biologically active lipopeptides as analogs for spirochetal lipoproteins. Pept. Res. 7:91.
70. Tai, F. K., Y. Ma, and J. J. Weis. 1994. Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotcin OspA. Infect. Immun. 62:520.
71. Weis, J. J., Y. Ma., and L. F. Erdile. 1994. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect. Immun. 62:4632.
72. Ma, Y., and J. J. Weis. 1993. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect. Immun. 61:3843.
73. Sellati, T. J., L. D. Abrescia, J. D. Radolf, M. B. Furie. 1996. Outer-surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro. Infect. Immun. 64:3180.
74. Radolf, J. D., M. V. Norgard, M. E. Brandt, R. D. Isaacs, P. A. Thompson, and B. Boutler. 1991. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis: analysis using a CAT reporter construct. J. Immunol. 147:1968.
75. Radolf, J. R., L. L. Arndt, D. R. Akings, L. L. Curetty, M. E. Levi, Y. Shen, L. S. Davis, and M. V. Norgard. 1995. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154:2866.
76. Norgard, M. V., L. L. Arndt, D. R. Akins, L. L. Curetty, D. A. Harrich, and J. R. Radolf. 1996. Activation of human monocytic cells by Treponema palladium and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of LPS but involves the transcriptional activator NF-κB. Inject. Immun. 64:3845.